Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Current Issues in Molecular Biology|February 25, 2025
Diagnostic Approaches in Myeloid SarcomaElzbieta Patkowska, Agnieszka Krzywdzinska, Iwona Solarska, et al.Hemasphere|March 15, 2024
Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia-positive lymphoid leukemia to tyrosine kinase inhibitorsLukasz Komorowski, Agnieszka Dabkowska, Joanna Madzio, et al.Blood Advances|April 8, 2026
Quizartinib in newly diagnosed patients with FLT3-ITD-positive AML who received maintenance therapy in QuANTUM-FirstMark J Levis, Harry P Erba, Pau Montesinos, et al.The Journal of Biological Chemistry|June 3, 2023
Efficient chimeric antigen receptor targeting of a central epitope of CD22Nicholas Paul Casey, Clara Helena Klee, Anne Fåne, et al.Oncogene|January 29, 2022
Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclaxKlaudyna Fidyt, Agata Pastorczak, Julia Cyran, et al.Cell Death & Disease|November 7, 2020
SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolismAnna Polak, Emilia Bialopiotrowicz, Beata Krzymieniewska, et al.Blood Advances|October 6, 2025
FLT3-ITD measurable residual disease from the QuANTUM-First trialMark J Levis, Harry P Erba, Pau Montesinos, et al.Blood|August 2, 2022
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapyEunice S Wang, Pau Montesinos, Mark D Minden, et al.Molecular Oncology|March 13, 2019
Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemiaKlaudyna Fidyt, Agata Pastorczak, Agnieszka Goral, et al.Leukemia & Lymphoma|November 14, 2014
Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group studyBozena Katarzyna Budziszewska, Agnieszka Pluta, Kazimierz Sulek, et al.Pageof 2